Authors
Min He, Xiaogang Zhu, Guohua Huang, Yangyang Wang, Xiaofang Liu, Min Xue, Jin Bai, Lian Zhang
Published in
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. Volume 43. Issue 1. Pages 2758964. Epub Nov 17, 2026.
Abstract
To evaluate the adverse events and complications associated with focused ultrasound ablation surgery(FUAS)for benign uterine diseases in teaching and training centers.
From October 2010 to December 2023, 26,844 patients with benign uterine diseases were treated with FUAS and more than 2000 doctors had been trained in three teaching and training centers. Among the treated patients, 16,619 had uterine fibroids, 8732 had adenomyosis, 1154 had cesarean scar pregnancy, and 379 had placental accreta spectrum. According to the classification system of the Society of Interventional Radiology (SIR), these adverse events were classified as mild adverse event (no therapy or nominal therapy), moderate adverse event (moderate escalation of care, requiring substantial treatment), severe adverse event (marked escalation of care), Life-threatening or disabling event, and patient death or unexpected pregnancy abortion.
Mild adverse effects occurred in 2,352 (8.75%) patients, moderate adverse events were seen in 147 (0.55%) patients, severe adverse events encountered in 50 (0.18%) patients. No life-threatening or disabling event, and patient death or unexpected pregnancy abortion occurred. The overall incidence rate of severe adverse events was 0.18% (n = 50). From 2010 to 2023, the annual incidence rates of severe adverse events were 0%, 0.42%, 0%, 0%, 0.28%, 0.23%, 0.09%, 0.08%, 0.20%, 0.28%, 0.44%, 0.16%, 0.16%, and 0.10%, respectively.
Based on the results, we concluded that FUAS is a safe treatment for benign uterine diseases. The training course for trainee did not increase the risk of severe adverse events.
PMID:
43041118
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0